Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis? - sprookjes - yvandenbroek - TriplyDB

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

http://www.wikidata.org/entity/Q33577429

about

Biomarkers as potential treatment targets in inflammatory bowel disease: A systematic review Smartphone Data in Rheumatoid Arthritis - What Do Rheumatologists Want?Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial.Effectiveness of a telehealth service delivery model for treating attention-deficit/hyperactivity disorder: a community-based randomized controlled trial.Pretreatment Prediction of Individual Rheumatoid Arthritis Patients' Response to Anti-Cytokine Therapy Using Serum Cytokine/Chemokine/Soluble Receptor Biomarkers.Pro: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab?Evaluation of humoral and cellular immune responses to a DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in normal rats.Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response Claims for disease-modifying therapy by Alberta non-insured health benefits clients.Patient goals in rheumatoid arthritis care: A systematic review and qualitative synthesis.Plasma microRNA expression profiles in Chinese patients with rheumatoid arthritis.Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial.Safety and immunogenicity of a novel therapeutic DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in normal rats.Advances in use of immunomodulatory agents--a rheumatology perspective.Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force Factors associated with the intensification of treatment in rheumatoid arthritis in clinical practice.Treat-to-Target Strategy for Fibromyalgia: Opening the Dialogue.Treat to target in systemic lupus erythematosus: a commentary.Implementing Treat-to-Target Practices for Chronic Pain Through Shared Decision Making: Requisites, Prospects, and Challenges.Inhibition of GSK-3β Alleviates Collagen II-Induced Rheumatoid Arthritis in Rats Telepsychiatrists' Medication Treatment Strategies in the Children's Attention-Deficit/Hyperactivity Disorder Telemental Health Treatment Study.Comparative effectiveness of adalimumab and etanercept for rheumatoid arthritis in the Brazilian Public Health System Patient-Reported Outcomes in Patients with Chronic Kidney Disease and Kidney Transplant-Part 1.A review of sarilumab for the treatment of rheumatoid arthritis.Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry.Patterns of the initiation of disease-modifying antirheumatic drugs in incident rheumatoid arthritis: a German perspective based on nationwide ambulatory drug prescription data

P2860

Q28087434-94166AA7-BBCB-42A0-94A0-F386658AB605 Q31055223-FE9BE46A-F7B9-4D1E-9B30-4D8716B035E7 Q35348182-A30622E8-F35C-46EB-B597-7026B3027ED3 Q35525874-F0D07048-82BB-4850-8A25-C84D020C65CA Q35691806-598404C9-DFD8-475F-A5D4-5E37D0A6928F Q35777619-5F202043-8FC5-4CB6-A1A4-C87687770DB0 Q35887085-6B734043-6561-4738-8336-B28178EE0D21 Q35915876-B036C8A8-552B-4B53-AD81-F70B8F29B2BC Q36112027-84E641E9-5942-4DDE-92C8-3C3E457C0956 Q36224398-88F92820-63DA-4720-9269-5B595E892D85 Q36618929-2719DDBC-362B-43F0-8F61-C585BC69955D Q37036355-9ED7C75D-E45C-43D1-AA79-AE95F859333D Q37320179-ED2E78A7-998F-4C64-B824-2272AFF5B143 Q38431512-153483B1-B7AA-43A3-8749-1AD2D0A56D0E Q38476881-0F4A13C4-6179-45FA-9D07-D3967D89E45B Q38559816-136765AF-C3D8-41F2-8D42-F6821849FF53 Q38889834-E474219E-7F0F-4C22-B6F0-B8FB3CD35999 Q38894396-03DA4853-A7CD-48B6-ABB4-EED0AA6773D7 Q38903417-5760808B-EEB8-4CF3-B3C6-7C40912D332F Q39840211-0B5E0726-EF19-4DBC-92A2-3BD865F199D6 Q41646489-DC9D1234-F006-4620-AC1B-FD543E14061E Q42734907-4DB06E9A-B949-4C8A-B168-0C06D55F1FED Q47550895-0060C2B6-CFEC-49C6-A3BE-E45E076B7D24 Q50086851-C8C73652-84F3-4F6B-865A-C4DD99DADBBB Q55086137-7051BFD4-0823-4242-B6FC-991899B88C4D Q57286440-C520A71B-96EC-41BD-82C5-9D86E362A1B8

P2860

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

http://www.wikidata.org/entity/Q33577429

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

@ast

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

@en

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

@nl

type

label

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

@ast

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

@en

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

@nl

prefLabel

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

@ast

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

@en

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

@nl

P1433

Q33577429-61F1FDAA-6CF6-4A63-9C3D-99412F3A6B06

P1476

Q33577429-D2E58BF6-9473-45AB-B738-A65293194DDE

P2093

Q33577429-2A4EEB95-55F6-433B-9904-688D0449C745

Q33577429-5282D828-7885-4B1A-9CC9-533BF6B8A849

Q33577429-549DBD0E-E2DB-46DA-9C3A-386FD2AFD879

Q33577429-6B5DD36C-E28F-4191-BB5B-4E379239B3B0

Q33577429-A9415193-0CF5-451D-9BB0-8BA14ED39B00

Q33577429-D5DB71A2-0E79-4E0E-84EA-7557FA8008A4

P2860

Q33577429-08DD5FBD-16BA-4B73-A670-F963D6AFFB06

Q33577429-0DFE7A64-8B4C-4EEA-A09E-45B8422885A9

Q33577429-13235948-DBFC-416B-B01F-C4D2E5C6E8E6

Q33577429-16A7AADB-95E6-47BE-B29A-C9C235A98914

Q33577429-1D255C5B-B3B5-4C15-AF1F-CA737BB46DC7

Q33577429-231B3E07-6216-435C-87E8-10575BED77E6

Q33577429-2FDCA195-D1E4-4693-AB25-2996A4FA028A

Q33577429-341FD493-4FA0-4EF5-BFF6-526E4E4F51B5

Q33577429-492F42B3-80E2-4EB1-8AA4-C39079FF08C1

Q33577429-50EF80BB-F52D-4B2A-9FAA-A5D96212F70A

P304

Q33577429-EF68FC86-7A69-4C15-94CA-63E1CC6BB7FC

P31

Q33577429-C0D8B44E-4792-4BB3-8329-5D75BD945847

P356

Q33577429-3CE03142-C1A7-4318-B045-2DC835BCE9E3

P433

Q33577429-3EBB3E2F-8A1F-4FC6-9D85-A0DF8D208A74

P478

Q33577429-180D52D2-366A-4D3F-8EA9-9C7C0CB3ACB7

P577

Q33577429-0E24B62E-9B3D-43DF-9E0E-27C8DD663139

P5875

Q33577429-B2F7ACAD-1E66-4D8B-ABEE-CBD2868658B6

P698

Q33577429-36516529-9179-4608-B9FE-182CD3B7C105

P932

Q33577429-3108ABB2-EDCA-40A5-9FBE-3C926FB9D003

P356

P1433

Arthritis & Rheumatology

P1476

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

@en

P2093

Asaf Bitton

http://www.w3.org/2001/XMLSchema#string

Daniel H Solomon

http://www.w3.org/2001/XMLSchema#string

Erika M Brown

http://www.w3.org/2001/XMLSchema#string

Helga Radner

http://www.w3.org/2001/XMLSchema#string

Jeffrey N Katz

http://www.w3.org/2001/XMLSchema#string

Liana Fraenkel

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Specialist nurse-led intervention to treat and control hypertension and hyperlipidemia in diabetes (SPLINT): a randomized controlled trial

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

High disease activity may not be sufficient to escalate care

Long-term effects of intensive glucose lowering on cardiovascular outcomes.

Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis.

Clinical inertia.

Treating rheumatoid arthritis to target: recommendations of an international task force.

P304

775-782

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.38323

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261802901

http://www.w3.org/2001/XMLSchema#string

P698

24757129

http://www.w3.org/2001/XMLSchema#string

P932

4012860

http://www.w3.org/2001/XMLSchema#string